Stelco (TSE:STLC) Price Target Lowered to C$15.00 at National Bank Financial

Share on StockTwits

Stelco (TSE:STLC) had its price objective lowered by National Bank Financial from C$17.00 to C$15.00 in a report released on Wednesday morning, BayStreet.CA reports. National Bank Financial currently has a sector perform rating on the stock.

A number of other analysts have also commented on the company. BMO Capital Markets began coverage on Encompass Health in a research note on Thursday, June 27th. They set an outperform rating and a $72.00 price objective on the stock. Goldman Sachs Group raised to a buy rating and set a GBX 1,180 ($15.42) price objective on the stock in a research note on Tuesday, June 4th. Finally, JPMorgan Chase & Co. increased their price objective on Masonite International from $66.00 to $71.00 and gave the company an overweight rating in a research note on Friday, May 3rd.

STLC opened at C$14.70 on Wednesday. The company has a current ratio of 2.15, a quick ratio of 1.29 and a debt-to-equity ratio of 20.12. The firm has a market capitalization of $1.32 billion and a price-to-earnings ratio of 4.90. Stelco has a 52 week low of C$13.60 and a 52 week high of C$26.30. The firm’s fifty day moving average is C$15.10.

Stelco Company Profile

Stelco Holdings Inc is Canada-based company and owner of one of the technologically advanced integrated steelmaking facilities in North America. The Company produce flat-rolled value-added steels, including coated, cold-rolled and hot-rolled steel products as well as metallurgical coke. With gauge, crown, and shape control, as well as reliable uniformity of mechanical properties, The Company’s steel products are supplied to customers in the construction, automotive and energy industries across Canada and the United States, as well as to a variety of steel service centers, which are regional distributors of steel products.

Read More: Book Value Per Share – BVPS

Receive News & Ratings for Stelco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stelco and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.